Since YKL-40 is known to be increased in patients suffering from myelofibrosis, we excluded the data of all the patients with a history of myelofibrosis from the analysis (3 patients, [8.6%] in cGVHD group and 3 patients, [14.3%] in control group). This evidence concerns the gene CHI3L1 and myelofibrosis.